Previous 10 | Next 10 |
2024-06-10 09:00:00 ET Summary Invesco Dow Jones Industrial Average Dividend ETF holds the 28 stocks of the Dow Jones paying a dividend, weighted based on yields. DJD is better balanced across sectors than its parent index but is quite concentrated in its top holdings. DJD loo...
2024-06-09 09:44:11 ET Summary Cullinan Therapeutics, Inc. has seen a recent pullback in its shares, but they are still up 50% since mid-April after rebranding and focusing on autoimmune diseases. The company's lead asset is zipalertinib, an oral EGFR inhibitor being evaluated in ...
2024-06-07 15:00:58 ET More on the markets Going Into June, SPY Or VXF, Which Is The Better Buy? (Technical Analysis) SPY: 2 Options To Balance Out A Highly Concentrated Index Bitcoin's Fading Action Is A Huge Warning For Stock Market Liquidity Citi – ...
2024-06-07 07:05:00 ET Summary Warren Buffett once opined on how to live off of dividends in retirement. We discuss a simple way to follow his advice on this. We also share how to further enhance the yield on this portfolio while still generating strong dividend growth and kee...
2024-06-06 20:59:58 ET Summary The Schwab U.S. Dividend Equity ETF has performed reasonably well over the years. However it has underperformed a similar strategy, which is buying a diversified portfolio of Dividend Aristocrat stocks. The Dividend Aristocrats have beaten the S&...
AMGEN TO PRESENT AT GOLDMAN SACHS 45TH ANNUAL GLOBAL HEALTHCARE CONFERENCE PR Newswire THOUSAND OAKS, Calif. , June 5, 2024 /PRNewswire/ -- Amgen (NASDAQ:AMGN) will present at the Goldman Sachs 45 th Annual Global Healthcare Conference at 9:20 a.m. ET on Mo...
2024-06-05 10:27:05 ET Summary "The Dow® [adds a stock] if the company has an excellent reputation, demonstrates sustained growth, and is of interest to a large number of investors... Sector representation...is also a consideration.”–Dow Jones & Co. The high...
2024-06-05 09:41:38 ET More on Amgen Amgen Is A Fantastic Dividend Growth Stock With A Weight-Loss Wild Card Amgen Stock: Poised To Break Out (Technical Analysis) Amgen, Inc. (AMGN) ATS and the Approval of IMDELLTRA Conference - (Transcript) SA Asks: Which we...
AMGEN ANNOUNCES POSITIVE RESULTS FOR PHASE 3 REGISTRATIONAL TRIAL EVALUATING UPLIZNA® (INEBILIZUMAB-CDON) FOR TREATMENT OF IMMUNOGLOBULIN G4-RELATED DISEASE (IgG4-RD) PR Newswire Data Show a Statistically Significant 87% Reduction in IgG4-RD Flares, With Primary and All K...
2024-06-04 14:46:03 ET Summary Revolution Medicines, Inc. stock has more than doubled since the market initially reacted negatively to a clinical update on its lead asset RMC-6236 in October 2023. The company's RAS(ON) inhibitors will be tested in two registrational trials for pan...
News, Short Squeeze, Breakout and More Instantly...
2024-07-18 10:30:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-07-15 07:58:00 ET Can a biotechnology company pay a generous dividend in 2024? The answer is definitely yes, as Amgen (NASDAQ: AMGN) is evidently unafraid to reward its loyal shareholders with quarterly cash payments. Just as importantly, Amgen is a recent revenue growe...
2024-07-14 06:30:00 ET Income investors don't have to settle for dividends that tread water. There are plenty of stocks to buy that offer growing dividends and are poised to keep the momentum going along with attractive dividend yields . Three Motley Fool contributors think they've ...